A Phase Ib/II Study of CS3008 in Subjects With Hepatocellular Carcinoma

Condition:   Hepatocellular Carcinoma Intervention:   Drug: CS3008 in combination with CS1001 Sponsor:   CStone Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials